TRADING
ECONOMICS
CALENDAR
INDICATORS
Countries
Indicators
MARKETS
Currencies
Stocks
Commodities
Bonds
Earnings
FORECASTS
Countries
Indicators
Currencies
Stocks
Commodities
Bonds
APPS
DATA
Download historical data for 20 million indicators using your browser.
Already a user? Login
API GATEWAY
Direct access to our calendar releases and historical data from your apps.
ALERTS
Receive releases for indicators in your mail inbox and set alerts for markets.
ESTIMATES
Join the world's largest survey of market forecasts and estimates for indicators.
IECONOMICS
Intelligent search to get instant answers with data and charts.
UECONOMICS
Drag & drop charts and store your calendar preferences in a dashboard.
Myanmar - Completeness of infant death reporting (% of reported infant deaths to estimated infant deaths)
Completeness of infant death reporting (% of reported infant deaths to estimated infant deaths) in Myanmar was reported at 58.01 % in 2008, according to the World Bank collection of development indicators, compiled from officially recognized sources.
Historical
Data
API
1Y
5Y
10Y
MAX
Column
Line
Area
Spline
Splinearea
Candlestick
Bars
Trend
Average(4)
Histogram
Variance
Mean
Maximum
Minimum
Export Data
API Access
OK
<iframe src='https://tradingeconomics.com/embed/?s=mmr.sp.dth.infr.zs%3aworldbank&lbl=0&v=201804300000v&h=300&w=600&ref=/myanmar/completeness-of-infant-death-reporting-percent-of-reported-infant-deaths-to-estimated-infant-deaths-wb-data.html' height='300' width='600' frameborder='0' scrolling='no'></iframe><br />source: <a href='https://tradingeconomics.com/myanmar/completeness-of-infant-death-reporting-percent-of-reported-infant-deaths-to-estimated-infant-deaths-wb-data.html'>tradingeconomics.com</a>
width
height
Preview
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.
Learn More
Register
Login
The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.
Learn More
Interested?
Click here to contact us
Completeness of infant death reporting is the number of infant deaths reported by national statistics authorities to the United Nations Statistics Division's Demography Yearbook divided by the number of infant deaths estimated by the United Nations Population Division.
Myanmar | Health
10.1
%
12.7
%
21.6
%
42
%
51.2
%
10.4
%
Total alcohol consumption per capita (liters of pure alcohol, projected estimates, 15+ years of age)
0.7
Prevalence of anemia among women of reproductive age (% of women ages 15-49)
46.3
%
Prevalence of anemia among children (% of children under 5)
52.9
%
Prevalence of anemia among non-pregnant women (% of women ages 15-49)
46
%
77.4
%
8005
Cause of death, by communicable diseases and maternal, prenatal and nutrition conditions (% of total)
23.8
%
Number of infant deaths
37545
Cause of death, by injury (% of total)
8.2
%
Number of under-five deaths
47763
Cause of death, by non-communicable diseases (% of total)
68
%
Number of neonatal deaths
23062
8.2
Adults (ages 15+) living with HIV
220000
Persons
AIDS estimated deaths (UNAIDS estimates)
7800
Female adults with HIV (% of population ages 15+ with HIV)
36.38
%
Prevalence of HIV, total (% of population ages 15-49)
0.8
%
Mortality rate, under-5 (per 1,000)
50.8
Mortality rate, under-5, female (per 1,000 live births)
46
Mortality rate, under-5, male (per 1,000 live births)
55.4
Under-5 mortality rate (per 1,000 live births): Q1 (lowest)
62.4
Under-5 mortality rate (per 1,000 live births): Q2
62.4
Under-5 mortality rate (per 1,000 live births): Q3
48.9
Under-5 mortality rate (per 1,000 live births): Q4
27.2
Under-5 mortality rate (per 1,000 live births): Q5 (highest)
17.2
Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70
24
%
Mortality rate; neonatal (per 1;000 live births)
24.5
Demand for family planning satisfied by modern methods (% of married women with demand for family planning)
58.5
%
Children (0-14) living with HIV
9300
Persons
Prevalence of HIV, female (% ages 15-24)
0.3
%
Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)
16.2
17.8
Prevalence of HIV, male (% ages 15-24)
0.4
%
Antiretroviral therapy coverage (% of people with advanced HIV infection)
55
%
Adults (ages 15+) newly infected with HIV
10000
Children (ages 0-14) newly infected with HIV
1000
Adults (ages 15+) and children (ages 0-14) newly infected with HIV
11000
Incidence of HIV (% of uninfected population ages 15-49)
0.04
%
% of females ages 15-49 having comprehensive correct knowledge about HIV (2 prevent ways and reject 3 misconceptions)
19.7
%
22.3
%
Children orphaned by HIV/AIDS
120000
Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)
87
%
Adults (ages 15+) and children (0-14 years) living with HIV
230000
Persons
Vaccinations (all vaccinations) (% of children ages 12-23 months): Q1 (lowest)
97.3
%
Vaccinations (all vaccinations) (% of children ages 12-23 months): Q2
95.7
%
Vaccinations (all vaccinations) (% of children ages 12-23 months): Q3
96.8
%
Vaccinations (all vaccinations) (% of children ages 12-23 months): Q4
98.4
%
Vaccinations (all vaccinations) (% of children ages 12-23 months): Q5 (highest)
98.1
%
Immunization, Hib3 (% of children ages 12-23 months)
90
%
Immunization, BCG (% of one-year-old children)
88
%
Vaccinations (BCG) (% of children ages 12-23 months): Q1 (lowest)
98.6
%
Vaccinations (BCG) (% of children ages 12-23 months): Q2
97.1
%
Vaccinations (BCG) (% of children ages 12-23 months): Q3
98
%
Vaccinations (BCG) (% of children ages 12-23 months): Q4
99.1
%
Vaccinations (BCG) (% of children ages 12-23 months): Q5 (highest)
98.9
%
Immunization, DPT (% of children ages 12-23 months)
90
%
Vaccinations (DPT 3) (% of children ages 12-23 months): Q1 (lowest)
97.5
%
Vaccinations (DPT 3) (% of children ages 12-23 months): Q2
96.3
%
Vaccinations (DPT 3) (% of children ages 12-23 months): Q3
97.3
%
Vaccinations (DPT 3) (% of children ages 12-23 months): Q4
99.1
%
Vaccinations (DPT 3) (% of children ages 12-23 months): Q5 (highest)
99.2
%
Immunization, measles (% of children ages 12-23 months)
91
%
Vaccinations (Measles) (% of children ages 12-23 months): Q1 (lowest)
98.4
%
Vaccinations (Measles) (% of children ages 12-23 months): Q2
96.3
%
Vaccinations (Measles) (% of children ages 12-23 months): Q3
97.7
%
Vaccinations (Measles) (% of children ages 12-23 months): Q4
99
%
Vaccinations (Measles) (% of children ages 12-23 months): Q5 (highest)
98.4
%
Vaccinations (no vaccinations) (% of children ages 12-23 months): Q1 (lowest)
0.9
%
Vaccinations (no vaccinations) (% of children ages 12-23 months): Q2
2.3
%
Vaccinations (no vaccinations) (% of children ages 12-23 months): Q3
1.8
%
Vaccinations (no vaccinations) (% of children ages 12-23 months): Q4
0.9
%
Vaccinations (no vaccinations) (% of children ages 12-23 months): Q5 (highest)
0.8
%
Immunization, Pol3 (% of one-year-old children)
89
%
Hospital beds
0.6
Community health workers
0.195
Nurses and midwives
0.93
Physicians
0.568
Specialist surgical workforce (per 100,000 population)
2.37
Notified cases of malaria (per 100;000 people)
71487
Incidence of malaria (per 1,000 population at risk)
11.8
Use of insecticide-treated bed nets (% of under-5 population)
11.1
%
Number of maternal mortality deaths
1700
Lifetime risk of maternal death (1 in: rate varies by country)
260
Lifetime risk of maternal death
0.3848
%
Prevalence of anemia among pregnant women
53.8
%
Prevalence of syphilis (% of women attending antenatal care)
0.9
%
Smoking prevalence, females (% of adults)
6.4
%
Smoking prevalence, males (% of adults)
31.6
%
Improved sanitation facilities (% of population with access)
79.6
%
Improved sanitation facilities, urban (% of urban population with access)
84.3
%
Pregnant women receiving prenatal care of at least four visits (% of pregnant women)
73.4
%
Antenatal care (any skilled personnel) (% of women with a birth): Q1 (lowest)
70.7
%
Antenatal care (any skilled personnel) (% of women with a birth): Q2
77.7
%
Antenatal care (any skilled personnel) (% of women with a birth): Q3
82.9
%
Antenatal care (any skilled personnel) (% of women with a birth): Q4
92.6
%
Antenatal care (any skilled personnel) (% of women with a birth): Q5 (highest)
97.4
%
Pregnant women receiving prenatal care
83.1
%
Antenatal care (doctor) (% of women with a birth): Q1 (lowest)
2
%
Antenatal care (doctor) (% of women with a birth): Q2
6.7
%
Antenatal care (doctor) (% of women with a birth): Q3
12.7
%
Antenatal care (doctor) (% of women with a birth): Q4
27.8
%
Antenatal care (doctor) (% of women with a birth): Q5 (highest)
61.6
%
Treatment of acute respiratory infection (ARI) (% of children under 5 taken to a health provider): Q1 (lowest)
62.5
%
Treatment of acute respiratory infection (ARI) (% of children under 5 taken to a health provider): Q2
65.1
%
Treatment of acute respiratory infection (ARI) (% of children under 5 taken to a health provider): Q3
72.1
%
Treatment of acute respiratory infection (ARI) (% of children under 5 taken to a health provider): Q4
75.3
%
Treatment of acute respiratory infection (ARI) (% of children under 5 taken to a health provider): Q5 (highest)
77.3
%
ARI treatment (% of children under 5 taken to a health provider)
69.3
%
Prevalence of acute respiratory infection (ARI) (% of children under 5): Q1 (lowest)
3
%
Prevalence of acute respiratory infection (ARI) (% of children under 5): Q2
2.3
%
Prevalence of acute respiratory infection (ARI) (% of children under 5): Q3
2.9
%
Prevalence of acute respiratory infection (ARI) (% of children under 5): Q4
2.6
%
Prevalence of acute respiratory infection (ARI) (% of children under 5): Q5 (highest)
1.8
%
Exclusive breastfeeding (% of children under 6 months)
23.6
%
Assistance during delivery (any skilled personnel) (% of births): Q1 (lowest)
51
%
Assistance during delivery (any skilled personnel) (% of births): Q2
63.5
%
Assistance during delivery (any skilled personnel) (% of births): Q3
68.7
%
Assistance during delivery (any skilled personnel) (% of births): Q4
82.7
%
Assistance during delivery (any skilled personnel) (% of births): Q5 (highest)
96.1
%
Births attended by skilled health staff (% of total)
60.2
%
Place of delivery (births at health facility) (% of births): Q1 (lowest)
12.4
%
Place of delivery (births at health facility) (% of births): Q2
23.1
%
Place of delivery (births at health facility) (% of births): Q3
31.2
%
Place of delivery (births at health facility) (% of births): Q4
48.9
%
Place of delivery (births at health facility) (% of births): Q5 (highest)
77.5
%
Assistance during delivery (doctor) (% of births): Q1 (lowest)
7.2
%
Assistance during delivery (doctor) (% of births): Q2
13.7
%
Assistance during delivery (doctor) (% of births): Q3
21.1
%
Assistance during delivery (doctor) (% of births): Q4
40.9
%
Assistance during delivery (doctor) (% of births): Q5 (highest)
69.3
%
Low-birthweight babies (% of births)
8.6
%
Prevalence of diarrhea (% of children under 5): Q1 (lowest)
7.8
%
Prevalence of diarrhea (% of children under 5): Q2
7.2
%
Prevalence of diarrhea (% of children under 5): Q3
6.8
%
Prevalence of diarrhea (% of children under 5): Q4
6.3
%
Prevalence of diarrhea (% of children under 5): Q5 (highest)
5
%
Prevalence of underweight, weight for age, female (% of children under 5)
22.1
%
Prevalence of underweight, weight for age, male (% of children under 5)
23
%
Malnourished children (underweight, -2SD) (% of children under 5): Q1 (lowest)
33.1
%
Malnourished children (underweight, -2SD) (% of children under 5): Q2
23.9
%
Malnourished children (underweight, -2SD) (% of children under 5): Q3
21.6
%
Malnourished children (underweight, -2SD) (% of children under 5): Q4
16.6
%
Malnourished children (underweight, -2SD) (% of children under 5): Q5 (highest)
13.5
%
Malnutrition prevalence, weight for age (% of children under 5)
22.6
%
Malaria cases reported
77842
Malnourished children (underweight, -3SD) (% of children under 5): Q1 (lowest)
9.7
%
Malnourished children (underweight, -3SD) (% of children under 5): Q2
6.3
%
Malnourished children (underweight, -3SD) (% of children under 5): Q3
4.8
%
Malnourished children (underweight, -3SD) (% of children under 5): Q4
2.9
%
Malnourished children (underweight, -3SD) (% of children under 5): Q5 (highest)
2.7
%
Maternal mortality ratio (modeled estimate, per 100,000 live births)
178
Maternal mortality ratio (national estimate; per 100;000 live births)
320
Diarrhea treatment (% of children under 5 receiving oral rehydration and continued feeding)
50.3
%
Diarrhea treatment (% of children under 5 who received ORS packet)
60.6
%
Prevalence of overweight, female (% of female adults)
27.8
%
Prevalence of overweight, male (% of male adults)
21.2
%
24.8
%
Prevalence of overweight, weight for height, female (% of children under 5)
2.6
%
Prevalence of overweight, weight for height, male (% of children under 5)
2.7
%
Prevalence of overweight (% of children under 5)
2.6
%
Malnourished children (stunting, -3SD) (% of children under 5): Q1 (lowest)
21
%
Malnourished children (stunting, -3SD) (% of children under 5): Q2
14.1
%
Malnourished children (stunting, -3SD) (% of children under 5): Q3
11.4
%
Malnourished children (stunting, -3SD) (% of children under 5): Q4
8.6
%
Malnourished children (stunting, -3SD) (% of children under 5): Q5 (highest)
5
%
Prevalence of stunting, height for age, female (% of children under 5)
33.4
%
Prevalence of stunting, height for age, male (% of children under 5)
36.7
%
Malnourished children (stunting, -2SD) (% of children under 5): Q1 (lowest)
46.6
%
Malnourished children (stunting, -2SD) (% of children under 5): Q2
39.6
%
Malnourished children (stunting, -2SD) (% of children under 5): Q3
35.7
%
Malnourished children (stunting, -2SD) (% of children under 5): Q4
27.7
%
Malnourished children (stunting, -2SD) (% of children under 5): Q5 (highest)
20.7
%
Malnutrition prevalence, height for age (% of children under 5)
35.1
%
Suicide mortality rate (per 100,000 population)
4.3
Mortality caused by road traffic injury (per 100,000 people)
19.5
Prevalence of wasting, weight for height, female (% of children under 5)
7.1
%
Prevalence of wasting, weight for height, male (% of children under 5)
8.7
%
Malnourished children (wasting, -2SD) (% of children under 5): Q1 (lowest)
9.9
%
Malnourished children (wasting, -2SD) (% of children under 5): Q2
7.8
%
Malnourished children (wasting, -2SD) (% of children under 5): Q3
7.1
%
Malnourished children (wasting, -2SD) (% of children under 5): Q4
7.2
%
Malnourished children (wasting, -2SD) (% of children under 5): Q5 (highest)
6.9
%
Prevalence of wasting (% of children under 5)
7.9
%
Malnourished children (wasting, -3SD) (% of children under 5): Q1 (lowest)
2.9
%
Malnourished children (wasting, -3SD) (% of children under 5): Q2
2.2
%
Malnourished children (wasting, -3SD) (% of children under 5): Q3
1.8
%
Malnourished children (wasting, -3SD) (% of children under 5): Q4
1.8
%
Malnourished children (wasting, -3SD) (% of children under 5): Q5 (highest)
1.8
%
Prevalence of severe wasting, weight for height, female (% of children under 5)
1.9
%
Prevalence of severe wasting, weight for height, male (% of children under 5)
2.4
%
Prevalence of severe wasting, weight for height (% of children under 5)
2.1
%
Tuberculosis treatment success rate (% of registered cases)
87
%
Tuberculosis case detection rate (all forms)
72
Incidence of tuberculosis (per 100,000 people)
361
Tuberculosis death rate (per 100,000 people)
47
60
Newborns protected against tetanus
87
%
External resources for health (% of total expenditure on health)
21.81
%
Out-of-pocket health expenditure (% of total expenditure on health)
50.69
%
Out-of-pocket health expenditure (% of private expenditure on health)
93.72
%
Health expenditure per capita
20.29
USD
Health expenditure per capita, PPP (constant 2005 international $)
103
54.09
%
Health expenditure, private (% of GDP)
1.23
%
Health expenditure, public (% of total health expenditure)
45.91
%
Health expenditure, public (% of government expenditure)
3.59
%
Health expenditure, public (% of GDP)
1.04
%
Health expenditure, total (% of GDP)
2.28
%
Refugee population by country or territory of asylum
0
Number of people who are undernourished
9100000
Depth of the food deficit (kilocalories per person per day)
103
Depth of hunger (kilocalories per person per day)
230
Consumption of iodized salt (% of households)
68.8
%
Vitamin A supplements for postpartum women (% of women with a birth): Q1 (lowest)
64.3
%
Vitamin A supplements for postpartum women (% of women with a birth): Q2
65.7
%
Vitamin A supplements for postpartum women (% of women with a birth): Q3
69.4
%
Vitamin A supplements for postpartum women (% of women with a birth): Q4
69.7
%
Vitamin A supplements for postpartum women (% of women with a birth): Q5 (highest)
63.6
%
Vitamin A supplements for children (% of children ages 6-59 months): Q1 (lowest)
53.7
%
Vitamin A supplements for children (% of children ages 6-59 months): Q2
59.8
%
Vitamin A supplements for children (% of children ages 6-59 months): Q3
57.7
%
Vitamin A supplements for children (% of children ages 6-59 months): Q4
58.1
%
Vitamin A supplements for children (% of children ages 6-59 months): Q5 (highest)
50.6
%
Vitamin A supplementation coverage rate (% of children ages 6-59 months)
94
%
Adolescent fertility rate (births per 1,000 women ages 15-19)
16.25
Completeness of infant death reporting (% of reported infant deaths to estimated infant deaths)
58.01
%
Completeness of total death reporting (% of reported total deaths to estimated total deaths)
100
%
Mortality rate, adult, female (per 1,000 female adults)
165
Mortality rate, adult, male (per 1,000 male adults)
227
Birth rate, crude
18
Death rate, crude
8.1
Current use of contraception (modern method) (% of married women): Q1 (lowest)
37.9
%
Current use of contraception (modern method) (% of married women): Q2
44.6
%
Current use of contraception (modern method) (% of married women): Q3
45.1
%
Current use of contraception (modern method) (% of married women): Q4
50
%
Current use of contraception (modern method) (% of married women): Q5 (highest)
51
%
Contraceptive prevalence, modern methods (% of women ages 15-49)
45.8
%
Current use of contraception (any method) (% of married women): Q1 (lowest)
38.3
%
Current use of contraception (any method) (% of married women): Q2
44.9
%
Current use of contraception (any method) (% of married women): Q3
45.4
%
Current use of contraception (any method) (% of married women): Q4
50.2
%
Current use of contraception (any method) (% of married women): Q5 (highest)
51.7
%
Contraceptive prevalence (% of women ages 15-49)
46
%
Mortality rate, infant, female (per 1,000 live births)
35.7
Mortality rate, infant (per 1,000 live births)
40.1
Mortality rate, infant, male (per 1,000 live births)
44.3
Infant mortality rate (per 1,000 live births): Q1 (lowest)
49.2
Infant mortality rate (per 1,000 live births): Q2
52.2
Infant mortality rate (per 1,000 live births): Q3
40.4
Infant mortality rate (per 1,000 live births): Q4
23.5
Infant mortality rate (per 1,000 live births): Q5 (highest)
13.2
Life expectancy at birth, female (years)
68.77
years
Life expectancy at birth, total (years)
66.39
years
Life expectancy at birth, male (years)
64.11
years
Fertility rate, total (births per woman)
2.23
Survival to age 65, female (% of cohort)
72.5
%
Survival to age 65, male (% of cohort)
63.07
%
22.5
%
16
%
Population ages 50-54, female (% of female population)
5.33
%
Completeness of birth registration, rural
63.5
%
Completeness of birth registration, urban
93.5
%
Completeness of birth registration
72.4
%
Unmet need for contraception (% of married women ages 15-49)
19.1
%
Related
Myanmar - Credit Rating at 15.00
Myanmar GDP per capita PPP at 5351.60 USD
Myanmar GDP per capita at 1420.50 USD
Myanmar GDP at 67.40 USD Billion
Myanmar Interest Rate at 10.00 percent
Myanmar Manufacturing PMI at 53.70
Myanmar Cpi Transportation at 105.11 Index Points
Myanmar Cpi Housing Utilities at 143.25 Index Points
Myanmar Consumer Price Index Cpi at 139.51 Index Points
Myanmar Inflation Rate MoM at 0.12 percent
Myanmar Inflation Rate at 5.11 percent
Myanmar Gold Reserves at 7.30 Tonnes
Myanmar Government Debt to GDP at 36.75 percent
Myanmar Government Budget at -4.40 percent of GDP
Myanmar Crude Oil Production at 16.00 BBL/D/1K
Myanmar Corruption Index at 30.00 Points
Myanmar Corruption Rank at 130.00
Myanmar Current Account to GDP at -6.50 percent
Myanmar Sales Tax Rate - Commercial Tax at 5.00 percent
Myanmar Personal Income Tax Rate at 25.00 percent
Latest
Turkey Leaves Key Rate at 8%
US New Home Sales Beat Forecasts
Swiss Trade Surplus Narrows in March
Australia Q1 Inflation Rate Steady at 1.9%
US Factory Growth Highest Since 2014: PMI
Hong Kong Inflation Rate Slows to 2.6% in March
Singapore Inflation Rate Slows to 0.2% in March
Week Ahead
Canada Inflation Rate Rises to 2.3%, Highest Since October 2014
Spain Trade Deficit Narrows 16.8% in February
Japan Inflation Rate at 3-Month Low of 1.1 % in March
Indonesia Leaves Monetary Policy Unchanged
US Initial Claims Decline to 232K in Latest Week
Hong Kong Jobless Rate Lowest Since 1998
Australia Jobless Rate Steady at 5.5% in March
New Zealand Inflation Slows Further in Q1
Canada Leaves Key Rate Steady at 1.25%
Russia Jobless Rate Drops to 5% in March as Expected
Eurozone March Inflation Rate Revised Lower to 1.3%
UK Inflation Rate Eases to a Year-Low in March
Myanmar
United States
United Kingdom
Euro area
China
Afghanistan
Albania
Algeria
Andorra
Angola
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia
Botswana
Brazil
Brunei
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Channel Islands
Chile
China
Colombia
Comoros
Congo
Costa Rica
Cote d Ivoire
Croatia
Cuba
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
East Asia and Pacific
East Timor
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Euro area
European Union
Europe and Central Asia
Faeroe Islands
Fiji
Finland
France
French Polynesia
Gabon
Gambia
Georgia
Germany
Ghana
Greece
Greenland
Grenada
Guam
Guatemala
Guinea
Guinea Bissau
Guyana
Haiti
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Isle of Man
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kazakhstan
Kenya
Kiribati
Kosovo
Kuwait
Kyrgyzstan
Laos
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macau
Macedonia
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Mauritania
Mauritius
Mayotte
Mexico
Micronesia
Moldova
Monaco
Mongolia
Montenegro
Morocco
Mozambique
Myanmar
Namibia
Nepal
Netherlands
Netherlands Antilles
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
North Korea
Norway
Oman
Pakistan
Palau
Panama
Palestine
Papua New Guinea
Paraguay
Peru
Philippines
Poland
Portugal
Puerto Rico
Qatar
Republic of the Congo
Romania
Russia
Rwanda
Samoa
Sao Tome and Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Asia
South Korea
South Sudan
Spain
Sri Lanka
Sudan
Suriname
Swaziland
Sweden
Switzerland
Syria
Taiwan
Tajikistan
Tanzania
Thailand
Timor Leste
Togo
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
Uruguay
Uzbekistan
Vanuatu
Venezuela
Vietnam
Virgin Islands
Yemen
Zambia
Zimbabwe
Calendar
Forecast
Indicators
News
Blog
Markets
Currency
GDP
GDP
GDP Annual Growth Rate
GDP per capita
GDP per capita PPP
Labour
Minimum Wages
Population
Unemployment Rate
Prices
Consumer Price Index Cpi
Cpi Housing Utilities
Cpi Transportation
Food Inflation
Inflation Rate
Inflation Rate Mom
Money
Deposit Interest Rate
Interest Rate
Trade
Balance of Trade
Crude Oil Production
Current Account
Current Account to GDP
Exports
Exports by Category
Exports by Country
Foreign Direct Investment
Gold Reserves
Imports
Imports by Category
Imports by Country
Terrorism Index
Tourist Arrivals
Government
Credit Rating
Government Budget
Government Debt to GDP
Holidays
Military Expenditure
Business
Competitiveness Index
Competitiveness Rank
Corruption Index
Corruption Rank
Ease Of Doing Business
Internet Speed
IP Addresses
Manufacturing Pmi
Taxes
Corporate Tax Rate
Personal Income Tax Rate
Sales Tax Rate
Climate
Precipitation
Temperature
TRADING
ECONOMICS
20M INDICATORS
50K MARKETS
196 COUNTRIES
HISTORICAL DATA
INDICATORS
ECONOMIC CALENDAR
FOREX
LIVE QUOTES
STOCKS
FORECASTS
COMMODITIES
RATINGS
BONDS
GET STARTED
Like this page? Share it
Facebook
Twitter
Google+
LinkedIn
TRADING ECONOMICS supports the UN Refugee Agency
DONATE